|
MDN1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.13039999477738E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.83570000036981E-07 |
| Normal-vs-Stage2 |
1.002640E-04 |
| Normal-vs-Stage3 |
1.82237999999391E-05 |
| Normal-vs-Stage4 |
3.71330000004111E-06 |
| Stage1-vs-Stage2 |
8.740000E-01 |
| Stage1-vs-Stage3 |
7.563200E-01 |
| Stage1-vs-Stage4 |
3.257800E-01 |
| Stage2-vs-Stage3 |
7.095800E-01 |
| Stage2-vs-Stage4 |
2.513400E-01 |
| Stage3-vs-Stage4 |
4.525000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.70899999496888E-08 |
| Normal-vs-AfricanAmerican |
2.80210000003223E-06 |
| Normal-vs-Asian |
2.160800E-04 |
| Caucasian-vs-AfricanAmerican |
6.349800E-01 |
| Caucasian-vs-Asian |
8.374500E-02 |
| AfricanAmerican-vs-Asian |
5.909900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.04470037860006E-10 |
| Normal-vs-Female |
7.757100E-04 |
| Male-vs-Female |
4.824100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.44489999998054E-06 |
| Normal-vs-Extreme_Weight |
8.3240003778684E-10 |
| Normal-vs-Obese |
3.781400E-04 |
| Normal-vs-Extreme_Obese |
1.68855000000079E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.399200E-01 |
| Normal_Weight-vs-Obese |
1.758190E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.378000E-01 |
| Extreme_Weight-vs-Obese |
4.540200E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.936800E-01 |
| Obese-vs-Extreme_Obese |
2.832300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.483570E-03 |
| Normal-vs-Age(41-60Yrs) |
1.353310E-04 |
| Normal-vs-Age(61-80Yrs) |
1.60999991116739E-10 |
| Normal-vs-Age(81-100Yrs) |
3.21499999955677E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.600400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.015810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.198500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.735100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.741900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.397200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.59619999954231E-07 |
| Normal-VS-Type2 PRCC |
2.18020046460765E-10 |
| Normal-VS-KIRP CIMP |
7.116100E-03 |
| Normal-VS-Unclassified PRCC |
4.241200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.680400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.228800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.093000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.489360E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.749500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.605400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.12560010995844E-11 |
| Normal-vs-N1 |
2.01979999999713E-05 |
| Normal-vs-N2 |
9.983700E-04 |
| N0-vs-N1 |
1.801440E-01 |
| N0-vs-N2 |
5.190000E-01 |
| N1-vs-N2 |
2.399200E-01 |
|
|
